Alan G. Olivero
- Molecular Biology
- Organic Chemistry top 10%
- Genetics top 5%
- Oncology
- Hematology top 10%
- Co-authors
- Beat WeidmannDieter SeebàchLaurent SalphatiJodie PangCharles EigenbrotChristopher D. MaycockDaniel KirchhoferLeo Widler
- Topics
- Glioma Diagnosis and Treatment (13 papers)Cancer Genomics and Diagnostics (6 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)
- Cited by
- GeneticsOrganic ChemistryHematology
- Partner nations
- United StatesSpainSwitzerland
In The Last Decade
Alan G. Olivero
26 papers receiving 586 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 312
- Organic Chemistry 200
- Genetics 160
- Oncology 89
- Hematology 73
Countries citing papers authored by Alan G. Olivero
This map shows the geographic impact of Alan G. Olivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Olivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Olivero more than expected).
Fields of papers citing papers by Alan G. Olivero
This network shows the impact of papers produced by Alan G. Olivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Olivero. The network helps show where Alan G. Olivero may publish in the future.
Co-authorship network of co-authors of Alan G. Olivero
This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Olivero. A scholar is included among the top collaborators of Alan G. Olivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Olivero. Alan G. Olivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 2 | |
| 6 | 10 | |
| 7 | 36 | |
| 8 | 30 | |
| 9 | 5 | |
| 10 | 20 | |
| 11 | 38 | |
| 12 | The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer | 5 |
| 13 | 57 | |
| 14 | 36 | |
| 15 | 39 | |
| 16 | 11 | |
| 17 | 7 | |
| 18 | 47 | |
| 19 | 33 | |
| 20 | 59 |
About Alan G. Olivero
Alan G. Olivero is a scholar working on Genetics, Cancer Research and Hematology, having authored 26 papers that have together received 618 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (6 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Genetics (160 citations), Organic Chemistry (200 citations) and Hematology (73 citations). Alan G. Olivero has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Beat Weidmann, Dieter Seebàch, Laurent Salphati, Jodie Pang, Charles Eigenbrot, Christopher D. Maycock, Daniel Kirchhofer, Leo Widler, Patrick Y. Wen and Timothy F. Cloughesy. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.